Metraipolis › archive › dc_bfd5285bcbb2

Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report — Europe PMC PMID:41542718

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41542718
DOI
10.1002/cnr2.70458
License (as archived)
solo-consultazione
Archived
2026-11-07T05:08:06.634Z
SHA-256 of the archived text
ba31b331367874e52356136451618af94df6bb33e299c1d4ba5aa364039d140b
Stable URL of this page
https://metraipolis.com/documento/dc_bfd5285bcbb2

How to cite

Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report — Europe PMC PMID:41542718 — Europe PMC (en), https://europepmc.org/article/MED/41542718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfd5285bcbb2 (Metraipolis archive dc_bfd5285bcbb2, sha256 ba31b331367874e52356136451618af94df6bb33e299c1d4ba5aa364039d140b)
BibTeX
@misc{dcbfd5285bcbb2,
  title = {Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report — Europe PMC PMID:41542718},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41542718},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfd5285bcbb2; sha256 ba31b331367874e52356136451618af94df6bb33e299c1d4ba5aa364039d140b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41542718. Agents can read the archived copy with the MCP tool read_document.